Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of “Moderate Buy” by Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have been assigned an average rating of “Moderate Buy” from the ten analysts that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $36.56.

A number of research analysts recently issued reports on the stock. KeyCorp initiated coverage on shares of Surgery Partners in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Bank of America assumed coverage on shares of Surgery Partners in a research note on Monday, December 16th. They set a “buy” rating and a $30.00 price target for the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a report on Friday, October 4th. Benchmark restated a “buy” rating and issued a $50.00 price objective on shares of Surgery Partners in a report on Monday, August 26th. Finally, UBS Group assumed coverage on Surgery Partners in a research report on Monday, October 14th. They set a “buy” rating and a $38.00 target price for the company.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in SGRY. King Street Capital Management L.P. bought a new stake in shares of Surgery Partners during the 3rd quarter valued at about $46,748,000. Royce & Associates LP boosted its holdings in shares of Surgery Partners by 12.2% during the 3rd quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock worth $16,451,000 after buying an additional 55,545 shares in the last quarter. Lombard Odier Asset Management Europe Ltd acquired a new stake in shares of Surgery Partners during the 2nd quarter worth approximately $4,163,000. Principal Financial Group Inc. acquired a new stake in shares of Surgery Partners during the 3rd quarter worth approximately $1,469,000. Finally, Rhumbline Advisers increased its stake in shares of Surgery Partners by 19.6% in the 2nd quarter. Rhumbline Advisers now owns 127,952 shares of the company’s stock valued at $3,044,000 after acquiring an additional 20,963 shares in the last quarter.

Surgery Partners Stock Up 8.2 %

Shares of NASDAQ:SGRY opened at $21.22 on Friday. Surgery Partners has a 52-week low of $19.50 and a 52-week high of $35.29. The company has a market capitalization of $2.70 billion, a PE ratio of -44.21, a price-to-earnings-growth ratio of 17.40 and a beta of 2.58. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a fifty day moving average of $25.99 and a 200-day moving average of $27.74.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company’s revenue was up 14.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.15 EPS. On average, equities analysts predict that Surgery Partners will post 0.71 EPS for the current fiscal year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.